HomeNews The Faucet on the Shoulder: Most cancers's Surprising Name News February 1, 2025 75 0 Purposeful Precision Drugs: The New Precision Oncology? August 6, 2026 The Story of Immune Checkpoint Inhibitors and Immunotherapy July 21, 2026 Reflections on Progress at ASCO 2026 June 23, 2026 NCI’s Message and High Priorities June 16, 2026 NCI’s Message and High Priorities May 4, 2026 After a second breast most cancers prognosis at 61, I confronted 17 rounds of chemo, surgical procedure and radiation, altering my perspective on life and resulting in a brand new regular. Share FacebookTwitterPinterestWhatsApp Previous articleTevimbra Plus Chemotherapy Might Enhance Survival in First-Line ESCCNext articleITM-11 Meets Section 3 Trial Major Finish Level of PFS in GEP-NETs Hot Topics Purposeful Precision Drugs: The New Precision Oncology? The Story of Immune Checkpoint Inhibitors and Immunotherapy Reflections on Progress at ASCO 2026 Load more Related Articles Editor - August 6, 2026Purposeful Precision Drugs: The New Precision Oncology? Editor - July 21, 2026The Story of Immune Checkpoint Inhibitors and Immunotherapy Editor - June 23, 2026Reflections on Progress at ASCO 2026 Load more
